Natch, Belluscura (BELL) makes positive noises about current sales in an RNS today. But a 20% US tariff on most of its product is surely going to screw it on margin as, in a competitive market it will have to swallow some of the cost. The CFO is leaving on May 2 to take up another job which, just over 2 months after a bailout placing is not a good sign. But it is the cash number that should horrify anyone who was foolish enough to take part in that placing.
Filed under: